Skip to main content

Table 1 Clinical features of CADASIL and CADASIL-like patients

From: The comparisons of phenotype and genotype between CADASIL and CADASIL-like patients and population-specific evaluation of CADASIL scale in China

Clinical manifestations

CADASIL patients (n = 24)

CADASIL-like patients (n = 92)

P

Age, years

55.08 ± 2.40

58.89 ± 0.86

0.072

Age at onset

52.67 ± 2.64

55.48 ± 0.88

0.200

Duration from first onset to diagnosis

2.00 ± 0.55

1.07 ± 0.25

0.104

History of vascular risk factors

Elevated blood pressure, %

33.33

76.09

0.000

Diabettes Mellitus, %

25.00

23.91

0.912

Cigarette smoking, %

58.33

47.83

0.359

Alcohol intake, %

25.00

23.91

0.912

Onset-manifestation

Migraine, %

33.33

23.91

0.348

acute cerebral events, %

66.67

58.70

0.477

psychiatric disturbances, %

25.00

13.04

0.261

cognitive impairment,%

41.67

41.30

0.974

Recurrent stroke, %

58.33

19.57

0.028

Presence of family history of migraine in at least 1 generation, %

25.00

4.35

0.005

Presence of family history of migrane in at least 2 generation, %

16.66

3.26

0.048

Presence of family history of acute cerebral events in at least 1 generation, %

41.66

8.70

0.000

Presence of family history of acute cerebral events in at least 2 generation, %

33.33

5.43

0.000

Presence of family history of psychiatric disturbance/cognitive impairment at least 1 generation, %

8.30

n.r

-

Presence of family history of psychiatric disturbance/cognitive impairment in at least 2 generation, %

n.r

n.r

-

CADASIL scale

16.2 ± 3.1 (10–22)

14.7 ± 2.5 (8–22)

0.047

  1. CADASIL indicates cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy; ICH intracranial hemorrhage; n.r, not reported